インサイダーの売却・購入履歴
| 自社株取引日 | 役員・従業員名 | 役員・従業員の役職 | 株式の種類 | 売却／購入 | 株数 | 株価 |
|---|---|---|---|---|---|---|
| 2022-11-01 | KIRCHGRABER, PAUL R | CEO, Covance Drug Development | 譲渡制限付株式ユニット | 購入 | 2,007 | $0.00 |
| 2022-11-01 | EISENBERG, GLENN A | Chief Financial Officer, EVP | 譲渡制限付株式ユニット | 購入 | 12,032 | $0.00 |
| 2022-11-01 | SCHECHTER, ADAM H | Director, President & CEO | 普通株式 | 購入 | 2,007 | $ |
| 2022-11-01 | SCHECHTER, ADAM H | Director, President & CEO | 普通株式 | 購入 | 893 | $222.56 |
| 2022-11-01 | SCHECHTER, ADAM H | Director, President & CEO | 譲渡制限付株式ユニット | 購入 | 2,007 | $0.00 |
| 2022-11-01 | KIRCHGRABER, PAUL R | CEO, Covance Drug Development | 普通株式 | 購入 | 2,007 | $ |
| 2022-11-01 | KIRCHGRABER, PAUL R | CEO, Covance Drug Development | 普通株式 | 購入 | 892 | $222.56 |
| 2022-11-01 | EISENBERG, GLENN A | Chief Financial Officer, EVP | 普通株式 | 購入 | 12,032 | $ |
| 2022-11-01 | EISENBERG, GLENN A | Chief Financial Officer, EVP | 普通株式 | 購入 | 5,348 | $222.56 |
| 2022-11-01 | EISENBERG, GLENN A | Chief Financial Officer, EVP | 普通株式 | 購入 | 9,170 | $0.00 |
| 2022-11-01 | EISENBERG, GLENN A | Chief Financial Officer, EVP | 譲渡制限付株式ユニット | 購入 | 9,170 | $0.00 |
| 2022-10-12 | KLIPHOUSE, KIRSTEN MARIE | Director | 譲渡制限付株式ユニット | 購入 | 333 | $0.00 |
| 2022-09-26 | EISENBERG, GLENN A | Chief Financial Officer, EVP | 普通株式 | 購入 | 4,844 | $210.21 |
| 2022-09-26 | EISENBERG, GLENN A | Chief Financial Officer, EVP | 普通株式 | 購入 | 2,830 | $211.86 |
| 2022-09-26 | EISENBERG, GLENN A | Chief Financial Officer, EVP | 普通株式 | 購入 | 5,627 | $209.29 |
| 2022-09-26 | EISENBERG, GLENN A | Chief Financial Officer, EVP | 普通株式 | 購入 | 11,699 | $211.13 |
| 2022-09-07 | CAVENEY, BRIAN J | EVP, President of Diagnostics | 普通株式 | 購入 | 44.338 | $231.20 |
| 2022-08-03 | EISENBERG, GLENN A | Chief Financial Officer, EVP | 普通株式 | 購入 | 1,500 | $254.88 |